RAB11A Promotes Cell Malignant Progression and Tumor Formation of Prostate Cancer via Activating FAK/AKT Signaling Pathway

<div>RAB11A promotes prostate cancer cell proliferation. (a) The mRNA and protein levels of RAB11A in PC-3 cells were detected by RT-qPCR and western blotting, respectively. (b) The viability of PC-3 cells was analyzed by the CCK-8 assay. (c) The proliferation of PC-3 cells was examined by a clone formation assay. PC-3 cells were transfected with si-NC, si-RAB11A, oe-NC, or oe-RAB11A. <svg height="10.7395pt" id="M11" style="vertical-align:-0.6370001pt" version="1.1" viewbox="-0.0498162 -10.1025 60.8498 10.7395" width="60.8498pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0091,0,0,-0.0091,0,-5.741)"><path d="M486 158C486 177 478 202 466 220C413 228 386 236 336 262C386 288 413 297 466 304C478 323 486 347 485 366C470 376 444 381 422 380C389 338 368 319 321 288C323 345 329 372 349 422C339 442 322 461 305 470C289 461 271 442 262 422C281 372 287 345 290 288C243 319 222 338 189 380C167 381 142 376 125 366C125 347 133 322 145 304C198 296 225 288 275 262C225 236 198 227 145 220C133 201 125 177 126 158C141 148 167 143 189 144C222 186 243 205 290 236C288 179 282 152 262 102C272 82 289 63 306 54C322 63 340 82 350 102C330 152 324 179 321 236C368 205 390 186 422 144C444 143 470 148 486 158Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,5.56,-5.741)"><path d="M486 158C486 177 478 202 466 220C413 228 386 236 336 262C386 288 413 297 466 304C478 323 486 347 485 366C470 376 444 381 422 380C389 338 368 319 321 288C323 345 329 372 349 422C339 442 322 461 305 470C289 461 271 442 262 422C281 372 287 345 290 288C243 319 222 338 189 380C167 381 142 376 125 366C125 347 133 322 145 304C198 296 225 288 275 262C225 236 198 227 145 220C133 201 125 177 126 158C141 148 167 143 189 144C222 186 243 205 290 236C288 179 282 152 262 102C272 82 289 63 306 54C322 63 340 82 350 102C330 152 324 179 321 236C368 205 390 186 422 144C444 143 470 148 486 158Z"></path></g><g transform="matrix(.013,0,0,-0.013,11.66,0)"><path d="M600 480C600 590 528 650 384 650H143L137 622C222 614 225 607 210 531L130 127C113 41 106 36 23 28L17 0H294L300 28C204 36 195 42 212 127L243 284L314 263C327 263 339 263 352 264C465 271 600 337 600 480ZM508 481C508 351 402 304 329 304C289 304 265 311 250 317L295 559C302 594 310 606 323 611C335 616 350 619 367 619C455 619 508 573 508 481Z"></path></g><g transform="matrix(.013,0,0,-0.013,25.493,0)"><path d="M512 -3V55L134 254V256L512 456V514L75 281V230L512 -3Z"></path></g><g transform="matrix(.013,0,0,-0.013,38.931,0)"><path d="M241 635C89 635 35 457 35 312C35 153 89 -12 240 -12C390 -12 443 166 443 312C443 466 390 635 241 635ZM238 602C329 602 354 454 354 312C354 172 330 22 240 22C152 22 124 173 124 313S148 602 238 602Z"></path></g><g transform="matrix(.013,0,0,-0.013,45.171,0)"><path d="M113 -12C146 -12 170 11 170 46C170 78 146 103 114 103S58 78 58 46C58 11 82 -12 113 -12Z"></path></g><g transform="matrix(.013,0,0,-0.013,48.135,0)"><path d="M241 635C89 635 35 457 35 312C35 153 89 -12 240 -12C390 -12 443 166 443 312C443 466 390 635 241 635ZM238 602C329 602 354 454 354 312C354 172 330 22 240 22C152 22 124 173 124 313S148 602 238 602Z"></path></g><g transform="matrix(.013,0,0,-0.013,54.375,0)"><path d="M384 0V27C293 34 287 42 287 114V635C232 613 172 594 109 583V559L157 557C201 555 205 550 205 499V114C205 42 199 34 109 27V0H384Z"></path></g></svg> vs. si-NC; <svg height="9.4034pt" id="M12" style="vertical-align:-0.6370001pt" version="1.1" viewbox="-0.0498162 -8.7664 70.077 9.4034" width="70.077pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M717 427H488V399C559 390 569 378 549 331C530 287 513 253 489 216C425 282 354 343 321 371C360 397 383 416 402 432C423 450 444 479 444 520C444 600 377 658 296 658C208 658 132 590 132 500C132 446 159 403 204 361C119 300 54 260 54 167C54 80 125 -14 251 -14C323 -14 389 22 461 118C494 84 536 37 548 23C560 10 615 -13 670 -18L677 -9C647 49 556 150 514 191C549 244 573 285 601 324C634 373 647 391 717 399V427ZM285 624C335 624 369 576 369 519C369 465 342 426 295 391C235 437 204 472 204 524C204 584 239 624 285 624ZM278 54C212 54 139 100 139 196C139 245 164 292 230 339C321 265 385 204 438 145C405 99 345 54 278 54Z"></path></g><g transform="matrix(.013,0,0,-0.013,9.321,0)"><path d="M717 427H488V399C559 390 569 378 549 331C530 287 513 253 489 216C425 282 354 343 321 371C360 397 383 416 402 432C423 450 444 479 444 520C444 600 377 658 296 658C208 658 132 590 132 500C132 446 159 403 204 361C119 300 54 260 54 167C54 80 125 -14 251 -14C323 -14 389 22 461 118C494 84 536 37 548 23C560 10 615 -13 670 -18L677 -9C647 49 556 150 514 191C549 244 573 285 601 324C634 373 647 391 717 399V427ZM285 624C335 624 369 576 369 519C369 465 342 426 295 391C235 437 204 472 204 524C204 584 239 624 285 624ZM278 54C212 54 139 100 139 196C139 245 164 292 230 339C321 265 385 204 438 145C405 99 345 54 278 54Z"></path></g><g transform="matrix(.013,0,0,-0.013,20.818,0)"><path d="M600 480C600 590 528 650 384 650H143L137 622C222 614 225 607 210 531L130 127C113 41 106 36 23 28L17 0H294L300 28C204 36 195 42 212 127L243 284L314 263C327 263 339 263 352 264C465 271 600 337 600 480ZM508 481C508 351 402 304 329 304C289 304 265 311 250 317L295 559C302 594 310 606 323 611C335 616 350 619 367 619C455 619 508 573 508 481Z"></path></g><g transform="matrix(.013,0,0,-0.013,34.651,0)"><path d="M512 -3V55L134 254V256L512 456V514L75 281V230L512 -3Z"></path></g><g transform="matrix(.013,0,0,-0.013,48.089,0)"><path d="M241 635C89 635 35 457 35 312C35 153 89 -12 240 -12C390 -12 443 166 443 312C443 466 390 635 241 635ZM238 602C329 602 354 454 354 312C354 172 330 22 240 22C152 22 124 173 124 313S148 602 238 602Z"></path></g><g transform="matrix(.013,0,0,-0.013,54.329,0)"><path d="M113 -12C146 -12 170 11 170 46C170 78 146 103 114 103S58 78 58 46C58 11 82 -12 113 -12Z"></path></g><g transform="matrix(.013,0,0,-0.013,57.293,0)"><path d="M241 635C89 635 35 457 35 312C35 153 89 -12 240 -12C390 -12 443 166 443 312C443 466 390 635 241 635ZM238 602C329 602 354 454 354 312C354 172 330 22 240 22C152 22 124 173 124 313S148 602 238 602Z"></path></g><g transform="matrix(.013,0,0,-0.013,63.533,0)"><path d="M384 0V27C293 34 287 42 287 114V635C232 613 172 594 109 583V559L157 557C201 555 205 550 205 499V114C205 42 199 34 109 27V0H384Z"></path></g></svg> vs. oe-NC.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: RAB11A Promotes Cell Malignant Progression and Tumor Formation of Prostate Cancer via Activating FAK/AKT Signaling Pathway 